Skip to content

Drug interactions

Duvelisib + Salmeterol

Severity: Moderate

Duvelisib and Salmeterol: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Duvelisib inhibits CYP3A4 and may increase salmeterol exposure. This may enhance cardiovascular effects such as tachycardia, QT prolongation and hypokalemia.

What this interaction means in plain words

Duvelisib and Salmeterol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Duvelisib belongs to Oncology; Salmeterol belongs to Respiratory.

Evidence level: Moderate

Why it happens

Inhibition of CYP3A4-mediated salmeterol metabolism by duvelisib.

What to do

Monitor heart rate, potassium and ECG if cardiac risk is present, and consider an alternative long-acting beta-agonist not reliant on CYP3A4. Counsel the patient to report palpitations or tremor.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Duvelisib and Salmeterol, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Duvelisib with Salmeterol?

MediHelp rates the interaction as moderate. Duvelisib and Salmeterol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Duvelisib inhibits CYP3A4 and may increase salmeterol exposure. This may enhance cardiovascular effects such as tachycardia, QT prolongation and hypokalemia.

How serious is the interaction between Duvelisib and Salmeterol?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor heart rate, potassium and ECG if cardiac risk is present, and consider an alternative long-acting beta-agonist not reliant on CYP3A4. Counsel the patient to report palpitations or tremor.

What other medicines interact with Salmeterol?

MediHelp also lists interactions of Salmeterol with, for example, Ritonavir, Saquinavir, Amitriptyline. The full list is on the Salmeterol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in